Navigation Links
Regado Biosciences, Inc. Announces Exercise of Over-Allotment Option
Date:9/6/2013

Times Square, New York, NY 10036, Telephone: (800) 414-3627, Email: bmoprospectus@bmo.com.

ABOUT REGADO BIOSCIENCES

Regado Biosciences, Inc. is a biopharmaceutical company focused on the discovery and development of novel, first-in-class, actively controllable antithrombotic drug systems for acute and sub-acute cardiovascular indications. Regado is pioneering the discovery and development of two-component drug systems consisting of a therapeutic aptamer and its specific active control agent. The company's lead product candidate, REG1, is an actively controllable anticoagulant targeting coagulation Factor IXa for use in patients with a wide variety of acute coronary syndromes, or ACS, undergoing a percutaneous coronary intervention, or PCI, a hospital-based procedure used to mechanically open or widen obstructed coronary arteries. The actively controllable product candidates have the potential to improve outcomes, enhance the patient experience and reduce overall treatment costs.  More information can be found at www.regadobio.com.

Contact:

Tiberend Strategic Advisors, Inc. 
Joshua Drumm, Ph.D./Andrew Mielach
jdrumm@tiberend.com; (212) 375-2664
amielach@tiberend.com; (212) 375-2694

 


'/>"/>
SOURCE Regado Biosciences, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Regado Biosciences, Inc. Files Registration Statement for Proposed Initial Public Offering
2. Regado Biosciences, Inc. to Present at Needham & Companys 11th Annual Healthcare Conference in New York, NY
3. Regado Biosciences, Inc. to Present at the Cowen and Company 32nd Annual Health Care Conference in Boston, MA
4. Pressure BioSciences, Inc. to Discuss Second Quarter 2013 Financial Results and Provide a Business Update
5. Pressure BioSciences, Inc. Closes Final Tranche of Series J Above Market Private Placement - Total Amount Raised in PIPE Slightly Exceeds $2 Million Goal
6. Pressure BioSciences, Inc. to Discuss First Quarter 2013 Financial Results and Provide Business Update
7. Pressure BioSciences, Inc. Appoints Conrad F. Mir as Chief Financial Officer
8. Pressure BioSciences, Inc. Continues Global Sales Reach Expansion with Distribution Agreements for China, Vietnam, Laos, Cambodia, Australia, and New Zealand
9. Pressure BioSciences, Inc. Reaches Agreement with Investors on Initial $600,000 Tranche of $1.2 Million Above-Market Private Placement; Proceeds to Support Continued Commercialization of PCT Product Platform
10. Shire to Acquire FerroKin BioSciences, Inc., and its Phase 2 Iron Chelator Treatment
11. Clinverse, Inc. Announces Strategic Partnership With OmniComm Systems, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... July 30, 2014  Decision Resources Group finds ... directors in the United States ... market penetration will be the level of savings ... the expected lower cost to patients. Payers plan ... meet their pricing expectations in order to encourage ...
(Date:7/30/2014)... 2014 A study presented at the ... efficacy of CSL Behring,s C1 Inhibitor (C1-INH) concentrate ... highly sensitized patients. C1-INH is a human protein ... The study shows that post-transplant treatment ... levels of complement components 3 and 4, suggesting ...
(Date:7/30/2014)... , July 30, 2014  The Chicago Bears are ... Academy of Dermatology (Academy) in an effort to raise ... Bears will host free SPOT me™ skin cancer screenings ... at Soldier Field. SPOT me™ is an educational ... the dangers and risks of skin cancer, and encourages ...
(Date:7/30/2014)... -- Replikins Ltd. today released new data on changes in ... current outbreaks, the mean Ebola Reston gene Replikin Count ... and 2002 was 1.1; the mean Replikin Count increased ... 2013, thus predicting the current outbreaks in humans. ... to be able to predict outbreaks (1).  For example, ...
Breaking Biology Technology:Surveyed U.S. Payers Expect Cost Savings to MCOs and Patients to be the Strongest Drivers of Biosimilar Uptake 2Surveyed U.S. Payers Expect Cost Savings to MCOs and Patients to be the Strongest Drivers of Biosimilar Uptake 3Study Suggests C1-INH May Aid in Prevention of Antibody-Mediated Rejection Following Kidney Transplant 2Study Suggests C1-INH May Aid in Prevention of Antibody-Mediated Rejection Following Kidney Transplant 3Chicago Bears Join the American Academy of Dermatology in Fight against Skin Cancer 2Chicago Bears Join the American Academy of Dermatology in Fight against Skin Cancer 3Chicago Bears Join the American Academy of Dermatology in Fight against Skin Cancer 4
... the 44th Annual Meeting of,the American Society of ... potential utility of Zevalin(R) (Ibritumomab,Tiuxetan) radioimmunotherapy as replacement ... in the treatment of non-Hodgkin,s,lymphoma (NHL). Cell Therapeutics, ... in the United States., "These two studies ...
... across multiple geographic scales ranging from vast climatic regions of ... molecular world of soil nano-particles in a pinch of soil. ... field, soil properties vary from the summit of a hill ... may be less than a quarter inch in diameter, there ...
... Given the increasing,challenges to patent protection and new ... to grow their pipelines.,With the increasing merger and ... proper integration of assets to be key in ... "M&A Integration,Excellence: What Bio- Pharma Companies Need to ...
Cached Biology Technology:Investigational Studies Highlight Potential Utility of Zevalin(R) (Ibritumomab Tiuxetan) Radioimmunotherapy in Stem Cell Transplantation for Non-Hodgkin's Lymphoma 2Investigational Studies Highlight Potential Utility of Zevalin(R) (Ibritumomab Tiuxetan) Radioimmunotherapy in Stem Cell Transplantation for Non-Hodgkin's Lymphoma 3Investigational Studies Highlight Potential Utility of Zevalin(R) (Ibritumomab Tiuxetan) Radioimmunotherapy in Stem Cell Transplantation for Non-Hodgkin's Lymphoma 4Sophisticated soil analysis for improved land use 2Bio-Pharma Industry Experts Deliver M&A Value Through Integration Excellence 2
(Date:7/30/2014)... study of dominance in female baboons suggests that the route ... mom, and to have lots of supportive sisters. , A ... strength, but by the rank of her mother - the ... be. For this reason, dominance rank in female baboons is ... mothers are guaranteed a good spot in the pecking order, ...
(Date:7/30/2014)... The Jackson Laboratory has received a pledge of $1 ... and name the Laboratory,s new Neurobehavioral Biometry Center. ... Biometry Center will enable the Laboratory to develop a ... with the ultimate goal of accelerating the pace of ... will serve as a premier resource for the Laboratory ...
(Date:7/30/2014)... associate professor Andrew S. Mount, performed cutting-edge research on ... novel anti-fouling paint for ships and boats and also ... team,s findings, published in Nature Communications ... attaches to a wide variety of surfaces using highly ... underwater heavy-duty adhesive. , "In previous research, we were ...
Breaking Biology News(10 mins):Supportive moms and sisters boost female baboon's rank 2Supportive moms and sisters boost female baboon's rank 3Rossi Foundation pledges $1M for JAX neurobehavioral research center 2Study: Marine pest provides advances in maritime anti-fouling and biomedicine 2
... HOUGHTON, Mich.--Mathematicians at Michigan Technological University have developed ... behind some of humanitys most intractable diseases. ... to pinpoint the genes behind inherited illness. With ... single nucleotide polymorphisms, SNPs or snipsassociated with type ...
... consume heavy metals have been found in some of the ... Pennines and may be changing the pollutants into more toxic ... tomorrow (Monday 31 March 2008) at the Society for General ... Centre. The U.K. has approximately 10 15 % ...
... not only smart, but they also wage a good ... studies have shown that plants can sense attacks by ... been known what happens between the pathogen attacks and ... revealed a very complex process that explains how plants ...
Cached Biology News:Michigan Tech researchers link 11 genetic variations to type 2 diabetes 2Heavy metals in the Peak District -- evidence from bugs in blanket bogs 2Researcher discovers pathway plants use to fight back against pathogens 2
... Lyophilized. Lyophilized from 2 mM sodium phosphate ... liver. Cathepsin D is a major lysosomal ... a 52 kDa proenzyme. Overexpression of cathepsin ... with higher risk of relapse and metastasis. ...
Acetate Plate Sealers 100/Box...
...
Rat Lung Fibroblasts (RLF) (>500,000 cells)...
Biology Products: